Trials / Completed
CompletedNCT04022954
HD Mapping of Atrial Fibrillation in Asia Pacific
HD Mapping Observational Study - Asia Pacific
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to quantify and characterize the outcomes of radiofrequency (RF) ablation after, and the utility of, electroanatomical mapping with the market-released HD mapping catheters Inquiry™ AFocusII™ Double Loop and Advisor™ HD Grid, Sensor Enabled™ with the EnSite Cardiac Mapping System and the EnSite Automap module in subjects with AF in the real-world environment of the Asian population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Catheter ablation | Inquiry AFocusII Double Loop and Advisor HD Grid, Sensor Enabled |
Timeline
- Start date
- 2019-09-11
- Primary completion
- 2021-08-13
- Completion
- 2021-08-13
- First posted
- 2019-07-17
- Last updated
- 2024-03-29
- Results posted
- 2024-03-29
Locations
15 sites across 5 countries: China, Hong Kong, Japan, South Korea, Taiwan
Source: ClinicalTrials.gov record NCT04022954. Inclusion in this directory is not an endorsement.